Nihon Shintatsu Co., Ltd.

(Incorporated in Japan)  We believe we are one of the leading real estate services and investment companies focused on tourism properties in Northern Japan. With our successful track record of property development and management, strong market position, and upcoming public listing, we are well-positioned to capitalize on Japan’s growing tourism sector. Our company has demonstrated […]

January 17, 2026 Read More

YCS Group Holdings

(Incorporated in the Cayman Islands) We are a Singapore-based corporate and consulting services provider. We serve small and medium-sized enterprises (SMEs) primarily in the Republic of Singapore. Our wide range of services support our clients from their inception through expansion, providing strategic insights and market expertise, facilitating efficient cross-border operations, and guiding them through compliance challenges […]

Read More

Yi Feng Holdings Ltd.

(Incorporated in the Cayman Islands) We are a holding company with operations in Hong Kong conducted by our operating subsidiaries, Yi Feng Construction M&E Limited and MCF Enginering Company Limited. We have been engaged in our operation in the construction industry since 2023, mainly as subcontractors. As a subcontractor, we provide our customers with (i) […]

Read More

SOLV Energy, Inc.

(Incorporated in Delaware) We are a leading provider of infrastructure services to the power industry, including engineering, procurement, construction, testing, commissioning, operations, maintenance and repowering. We have constructed more than 500 power plants representing 20 GWdc of generating capacity since we were founded in 2008, and we currently provide O&M (operations and maintenance) services under […]

Read More

SpyGlass Pharma, Inc.

(Incorporated in Delaware) We are a late-stage biopharmaceutical company dedicated to transforming the treatment paradigm for patients living with chronic eye conditions – specifically, open-angle glaucoma (OAG) or ocular hypertension (OHT) – through long-acting sustained drug delivery of approved medicines. Our mission is to significantly improve the lives of these patients by developing durable drug […]

January 16, 2026 Read More

AgomAb Therapeutics

(Incorporated in Belgium) We are a Phase 2 clinical biotech focused on discovering and/or developing new treatments for diseases in the immunology and inflammatory category. Our leading product candidates are: *Ontunisertib (AGMB-129) – An oral treatment for Crohn’s disease with fibrostenosis, and *AGMB-447 –  An inhaled treatment for idiopathic pulmonary fibrosis (IPF). Our product candidates […]

Read More

Rank One Computing Corp.

(Incorporated in Colorado) Founded in 2015, ROC is a consistently top-tier rated U.S.-built, U.S.-owned, and U.S.-operated provider of advanced biometric, facial recognition, and Vision AI solutions. We develop and deploy innovative technologies that enhance safety, security, and convenience globally, while upholding principles of fairness and privacy. Our solutions are trusted by U.S. and international military […]

January 14, 2026 Read More

AGI

(Incorporated in the Cayman Islands) Our journey began over 25 years ago with a vision from our founder, Mr. Marciano Testa: to make credit more accessible and affordable for the Brazilian consumers who needed it most. While still a college student in 1999, Mr. Testa founded Agiplan, the first building block of what eventually became […]

Read More

Liftoff Mobile (April 2026)

(Incorporated in Delaware) Note: Liftoff Mobile revived its IPO plans with a new S-1 filing on April 17, 2026. This IPO filing succeeded Liftoff Mobile’s previous IPO plan, which was withdrawn in mid-February 2026 after the IPO was postponed at the last minute amid a huge sell-off in the overall U.S. stock market.) Liftoff is […]

Read More

Veradermics, Inc.

(Incorporated in Delaware) We are a clinical biotech working to develop an oral treatment – called VDPHL01 – for pattern hair loss (PHL) in men and women in Phase II and Phase III clinical trials. VDPHL01 is an oral extended-release (ER) formulation of minoxidil, which was originally designed to treat resistant hypertension. We are currently […]

Read More